Ocugen (OCGN) Non Operating Income (2014 - 2026)
Ocugen (OCGN) posted Non Operating Income of -$1.3 million for Q1 2026, down 88.19% on a QoQ basis from -$711000.0 in Q4 2025, and down 57.6% year-over-year from -$3.2 million in Q1 2025.
Ocugen (OCGN) Non Operating Income (2014 - 2026) Analysis & Trends
Ocugen's Non Operating Income history runs 13 years deep, the most recent figure standing at -$1.3 million for Q1 2026.
- Quarterly Non Operating Income fell 57.6% year-over-year to -$1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.4 million (down 613.75% YoY) and the FY2025 annual result came in at -$4.9 million, down 801.28% from the prior year.
- Non Operating Income was -$1.3 million for Q1 2026 at Ocugen, down from -$711000.0 in the prior quarter.
- Across five years, Non Operating Income topped out at $1.2 million in Q3 2022 and bottomed at -$2.4 million in Q3 2025.
- A 5-year average of -$15411.8 and a median of $94000.0 in 2022 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2022 — Non Operating Income jumped 10777.78% — and 2025, when it plunged 8390.0%.
- Ocugen's Non Operating Income stood at $961000.0 in 2022, then sank by 42.25% to $555000.0 in 2023, then plunged by 107.21% to -$40000.0 in 2024, then plunged by 1677.5% to -$711000.0 in 2025, then plunged by 88.19% to -$1.3 million in 2026.
- Business Quant data shows OCGN's Non Operating Income at -$1.3 million in Q1 2026, -$711000.0 in Q4 2025, and -$2.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 444,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -8.59 Mn |
| 10 | Ocugen | 399.60 Mn | 399.60 Mn | - | -1.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.34 Mn |
| Dec 31, 2025 | -711,000.00 |
| Sep 30, 2025 | -2.43 Mn |
| Jun 30, 2025 | 114,000.00 |
| Mar 31, 2025 | -849,000.00 |
| Dec 31, 2024 | -40,000.00 |
| Sep 30, 2024 | 282,000.00 |
| Jun 30, 2024 | -4,000.00 |
| Mar 31, 2024 | -10,000.00 |
| Dec 31, 2023 | 555,000.00 |
| Sep 30, 2023 | 714,000.00 |
| Jun 30, 2023 | 475,000.00 |
| Mar 31, 2023 | 709,000.00 |
| Dec 31, 2022 | 961,000.00 |
| Sep 30, 2022 | 1.20 Mn |
| Jun 30, 2022 | 94,000.00 |
| Mar 31, 2022 | 15,000.00 |
| Dec 31, 2021 | -9,000.00 |
| Sep 30, 2021 | -18,000.00 |
| Jun 30, 2021 | -342,000.00 |